C Jouannaud Selected Research

Bevacizumab (Avastin)

1/2016	A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study.
1/2016	Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Jouannaud Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
2	Triple Negative Breast Neoplasms 01/2021 - 08/2014
2	Neoplasms (Cancer) 01/2016 - 08/2014
1	Neoplasm Metastasis (Metastasis) 01/2021

Drug/Important Bio-Agent (IBA)

2	Hormones (Hormone)IBA 01/2021 - 01/2017
2	Bevacizumab (Avastin)FDA Link 01/2016 - 01/2016
2	taxaneIBA 01/2016 - 08/2014
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018
1	Fluorouracil (Carac)FDA LinkGeneric 12/2018
1	Letrozole (Femara)FDA LinkGeneric 12/2018
1	Phenobarbital (Luminal)FDA Link 12/2018
1	Docetaxel (Taxotere)FDA Link 12/2018
1	Epirubicin (Ellence)FDA LinkGeneric 12/2018
1	palbociclibIBA 12/2018
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	exemestane (Aromasin)FDA Link 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Panitumumab (Vectibix)FDA Link 08/2014
1	Keratin-8 (Keratin 8)IBA 08/2014
1	AnthracyclinesIBA 08/2014
1	ParaffinIBA 08/2014
1	Growth Factor ReceptorsIBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 08/2014

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 12/2018 - 08/2014
4	Therapeutics 01/2021 - 01/2016
2	Neoadjuvant Therapy 12/2018 - 01/2017
1	Segmental Mastectomy (Lumpectomy) 12/2018